More than 11,000 bottles of a widely prescribed blood pressure medication have been recalled nationwide
According to the Food and Drug Administration’s enforcement report, the recalled medication failed dissolution specifications, meaning the tablets may not dissolve as intended in the body.
More than 11,000 bottles of a widely prescribed blood pressure medication have been recalled nationwide after a manufacturing issue was discovered, according to federal records.
The recall affects both 100-count and 1,000-count bottles distributed in the United States by Rising Pharma Holdings Inc. of New Jersey.
Inventia Healthcare Limited initiated the voluntary recall of Chlorthalidone Tablets USP, 25 mg on June 5.
Chlorthalidone is commonly prescribed to treat high blood pressure and fluid retention.
Chlorthalidone is commonly prescribed to treat high blood pressure and fluid retention.
The recall involves:
- 100-count bottles: Lot RISA24001, expiration date April 2027
- 1,000-count bottles: Lot RISB24002, expiration date April 2027
A total of 11,460 bottles are included in the recall.
The FDA has not yet assigned a classification to the recall, and no public press release has been issued.
